Cervical cancer screening programs in Latin America: current recommendations for facing elimination challenges

dc.contributor.authorFernández Deaza, Ginna
dc.contributor.authorCaicedo Martínez, Maria
dc.contributor.authorSerrano, Beatriz
dc.contributor.authorRoura Fornells, Esther
dc.contributor.authorCastillo, Juan Sebastián
dc.contributor.authorSanjosé Llongueras, Silvia de
dc.contributor.authorBruni, Laia
dc.contributor.authorMurillo, Raúl
dc.date.accessioned2023-01-18T17:48:31Z
dc.date.available2023-01-18T17:48:31Z
dc.date.issued2022-07-08
dc.date.updated2023-01-16T09:39:21Z
dc.description.abstractObjective. To describe current cervical cancer screening program guidelines in Latin America. Materials and methods. We searched official recommendations for the general population and women living with HIV (WLHIV) by reviewing official sources from 19 countries; these data were supplemented with a consultation carried out by the WHO with the Ministries of Health. Results. Screening policies vary significantly in regard to target populations, primary tests, and screening intervals. Sixteen countries have recently updated their recommendations; however, cytology remains the primary screening test for most countries.Eleven countries have introduced HPV tests, and eight countries have implemented screen-and-treat algorithms; only three countries have developed evidence-based guidelines. All countries but Costa Rica have specific recommendations for WLHIV. Conclusions. Although most countries have updated their screening policies, only a few are properly aligned with the WHO elimination strategy. Recommendations for WLHIV require better integration with cervical cancer screening programs.
dc.format.extent9 p.
dc.format.mimetypeapplication/pdf
dc.identifier.issn0036-3634
dc.identifier.pmid36130384
dc.identifier.urihttps://hdl.handle.net/2445/192292
dc.language.isoeng
dc.publisherInstituto Nacional de Salud Publica de Mexico
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.21149/13204
dc.relation.ispartofSalud Pública de México, 2022, vol. 64, num. 4, p. 415-423
dc.relation.urihttps://doi.org/10.21149/13204
dc.rightscc by-nc-sa (c) Fernández Deaza, Ginna et al., 2022
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by-sa/3.0/es/*
dc.sourceArticles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))
dc.subject.classificationMedicina preventiva
dc.subject.classificationAmérica latina
dc.subject.classificationCàncer de coll uterí
dc.subject.classificationCribratge
dc.subject.otherPreventive medicine
dc.subject.otherLatin America
dc.subject.otherCervix cancer
dc.subject.otherMedical screening
dc.titleCervical cancer screening programs in Latin America: current recommendations for facing elimination challenges
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
13204-Texto del artículo-64557-2-10-20220711.pdf
Mida:
437.94 KB
Format:
Adobe Portable Document Format